H1N1 vaccine market
Pharmaceuticals

H1N1 Vaccine Market Size, Share, And Growth Rate Analysis 2023

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s H1N1 vaccine market report forecasts the H1N1 vaccine market size to grow to $4.04 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The H1N1 Vaccine Market Report 2023 – https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report

H1N1 Vaccine Market Size Forecast
The global H1N1 vaccine market is expected to grow from $2.94 billion in 2022 to $3.14 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The H1N1 vaccine market size is expected to grow to $4.04 billion in 2027 at a CAGR of 6.5%.

North America held the largest H1N1 vaccine market share.

Key H1N1 Vaccine Market Driver ­– Increase In Expenditure For Research And Development Activities In The Field Of Immunology And Vaccine
For instance, according to an article by the kENUP Foundation, a Europe-based non-profit supporting research-based innovation in health industries, in January 2021, governments spent at least $94.11 billion (€93 billion) on the development of vaccines and treatments since the start of the pandemic worldwide. The public sector committed 95% of the total spending, or $87.54 billion (€86.5 billion), in just 11 months to the development of vaccinations. Therefore, increasing expenditure for research and development activities in the field of immunology and vaccines is driving the growth of the H1N1 vaccine market.

Request for A Sample Of The Global H1N1 Vaccine Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7881&type=smp

Key H1N1 Vaccine Market Trend – Technological Advancement
Major companies operating in the ADAS market are focused on developing new technological solutions to strengthen their position through the implementation of next-generation ADAS technologies into their products such as sensor fusion, embedded vision, HMI, software infrastructure, and autosar.

H1N1 Vaccine Market Segment
1) By System Type: Tire Pressure Monitoring System (TPMS), Drowsiness Monitor System, Intelligent Parking Assist System (IPAS), Adaptive Cruise Control System, Blind Spot Object Detection System, Lane Departure Warning System, Adaptive Front-lighting System, Others 

H1N1 Vaccine Market Major Players and Strategies
Major players in the H1N1 vaccine market are Continental AG, Denso, Magna International, Robert Bosch, NXP Semiconductors, Panasonic, Renesas Electronics, Texas Instruments, Hyundai Mobis, ZF Friedrichshafen, Mobileye, Autoliv Inc, Nvidia, Hitachi, and TRW Automotive Holdings Corp.

In December 2021, Baxter, a US-based healthcare company acquired Hillrom for the deal of the $15 billion amount. This acquisition unites two leading MedTech organizations in a shared vision for transforming healthcare and advancing patient care worldwide. Hillrom is a US-based medical technology provider.

The H1N1 Vaccine Global Market Report 2023 covers regional data on H1N1 vaccine market size, H1N1 vaccine market trends and drivers, opportunities, strategies, and H1N1 vaccine market competitor analysis. The countries covered in the H1N1 vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

H1N1 vaccines are administered to people six months of age and older to immunize them against influenza diseases brought on by the H1N1 2009 virus. These are used to prevent humans from Influenza virus infection by injecting a small dose of the virus inside the body to build immunity against the virus.

View More Reports Related To The H1N1 Vaccine Market –
Pediatric Vaccine Global Market Report 2023
Veterinary Vaccines Global Market Report 2023
DTP Vaccines Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: